Pembrolizumab Active in Non-Clear Cell Kidney Cancer Pembrolizumab Active in Non-Clear Cell Kidney Cancer
Pembrolizumab monotherapy demonstrated promising antitumor activity when used as a first-line therapy agent in patients with non-clear cell renal carcinoma.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Health | Hematology | Kidney Cancer | Urology & Nephrology